A Study to Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States
Clinical trial NCT06851065 · COMPLETED
Trial details
- NCT number
- NCT06851065
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-22
- Primary completion
- 2025-03-10
- Enrollment
- 418
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.